Compare Stocks: UPST, PRG, RSI, and VVOS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
PRG PROG	$30.42 -1.6%	$37.45	$25.80 ▼ $47.73	$1.21B	1.78	756,412 shs	525,275 shs
RSI Rush Street Interactive	$18.90 -7.0%	$24.19	$15.51 ▼ $34.53	$4.38B	1.71	3.72 million shs	2.67 million shs
UPST Upstart	$24.10 -0.4%	$27.18	$22.56 ▼ $55.22	$2.35B	2.43	4.48 million shs	2.68 million shs
VVOS Vivos Therapeutics	$0.15 -0.4%	$0.22	$0.13 ▼ $3.28	$2.07M	6.11	4.99 million shs	8.81 million shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
PRG PROG	0.00%	-1.84%	-18.09%	-31.32%	+0.12%
RSI Rush Street Interactive	0.00%	-5.41%	-28.02%	-43.39%	+3.56%
UPST Upstart	0.00%	+5.66%	-3.98%	-26.39%	-53.44%
VVOS Vivos Therapeutics	0.00%	-1.91%	-18.01%	-65.53%	-95.35%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
PRG PROG	$30.42 -1.6%	$37.45	$25.80 ▼ $47.73	$1.21B	1.78	756,412 shs	525,275 shs
RSI Rush Street Interactive	$18.90 -7.0%	$24.19	$15.51 ▼ $34.53	$4.38B	1.71	3.72 million shs	2.67 million shs
UPST Upstart	$24.10 -0.4%	$27.18	$22.56 ▼ $55.22	$2.35B	2.43	4.48 million shs	2.68 million shs
VVOS Vivos Therapeutics	$0.15 -0.4%	$0.22	$0.13 ▼ $3.28	$2.07M	6.11	4.99 million shs	8.81 million shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
PRG PROG	0.00%	-1.84%	-18.09%	-31.32%	+0.12%
RSI Rush Street Interactive	0.00%	-5.41%	-28.02%	-43.39%	+3.56%
UPST Upstart	0.00%	+5.66%	-3.98%	-26.39%	-53.44%
VVOS Vivos Therapeutics	0.00%	-1.91%	-18.01%	-65.53%	-95.35%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
PRG PROG	2.70	Moderate Buy	$47.81	57.20% Upside
RSI Rush Street Interactive	2.86	Moderate Buy	$34.20	80.96% Upside
UPST Upstart	2.35	Hold	$43.75	81.54% Upside
VVOS Vivos Therapeutics	2.25	Hold	$2.80	1,780.46% Upside

Current Analyst Ratings Breakdown

Latest UPST, PRG, RSI, and VVOS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/9/2026	RSI Rush Street Interactive	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Positive	$37.00 ➝ $27.00
10/8/2026	PRG PROG	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$45.00
10/7/2026	PRG PROG	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$60.00 ➝ $50.00
10/6/2026	UPST Upstart	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$42.00
10/2/2026	PRG PROG	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C+) ➝ Hold (C)
9/28/2026	RSI Rush Street Interactive	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C+) ➝ Hold (C)
9/28/2026	UPST Upstart	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
9/28/2026	PRG PROG	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
9/22/2026	RSI Rush Street Interactive	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Outperform
9/22/2026	RSI Rush Street Interactive	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Outperform	$34.00
9/22/2026	UPST Upstart	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$43.00

(Data available from 10/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
PRG PROG	$2.41B	0.50	$44.08 per share	0.69	$18.86 per share	1.61
RSI Rush Street Interactive	$1.13B	3.86	$0.44 per share	43.10	$1.32 per share	14.32
UPST Upstart	$1.04B	2.25	$0.81 per share	29.89	$8.21 per share	2.94
VVOS Vivos Therapeutics	$17.44M	0.12	N/A	N/A	($0.16) per share	-0.93

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
PRG PROG	$146.79M	$3.62	8.40	5.51	N/A	5.57%	21.88%	9.15%	10/28/2026 (Estimated)
RSI Rush Street Interactive	$33.31M	$0.29	65.17	29.08	N/A	2.33%	18.88%	8.57%	10/28/2026 (Estimated)
UPST Upstart	$53.60M	$0.49	49.18	13.85	0.85	4.84%	7.13%	1.82%	11/3/2026 (Estimated)
VVOS Vivos Therapeutics	-$21.17M	-$1.90	N/A	N/A	N/A	-122.00%	-2,325.64%	-102.01%	11/18/2026 (Estimated)

Latest UPST, PRG, RSI, and VVOS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/3/2026	Q3 2026	UPST Upstart	$0.2225	N/A	N/A	N/A	$365.52 million	N/A
10/28/2026	Q3 2026	PRG PROG	$1.09	N/A	N/A	N/A	$737.83 million	N/A
10/28/2026	Q3 2026	RSI Rush Street Interactive	$0.1381	N/A	N/A	N/A	$391.83 million	N/A
8/14/2026	Q2 2026	VVOS Vivos Therapeutics	-$0.41	-$0.31	+$0.10	-$0.31	$5.63 million	$5.15 million
8/4/2026	Q2 2026	UPST Upstart	$0.1782	$0.16	-$0.0182	$0.16	$354.74 million	$364.71 million
7/29/2026	Q2 2026	PRG PROG	$0.9470	$1.19	+$0.2430	$0.91	$713.50 million	$719.72 million
7/29/2026	Q2 2026	RSI Rush Street Interactive	$0.1499	$0.15	+$0.0001	$0.10	$367.75 million	$393.78 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
PRG PROG	$0.56	1.84%	-44.37%	15.47%	2 Years
RSI Rush Street Interactive	N/A	N/A	N/A	N/A	N/A
UPST Upstart	N/A	N/A	N/A	N/A	N/A
VVOS Vivos Therapeutics	N/A	N/A	N/A	N/A	N/A

Latest UPST, PRG, RSI, and VVOS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/5/2026	PRG PROG	quarterly	$0.14	1.35%	8/18/2026	8/18/2026	9/3/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
PRG PROG	1.10	4.03	2.29
RSI Rush Street Interactive	N/A	2.12	2.12
UPST Upstart	N/A	0.49	0.49
VVOS Vivos Therapeutics	N/A	0.21	0.21

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
PRG PROG	97.92%
RSI Rush Street Interactive	24.78%
UPST Upstart	63.01%
VVOS Vivos Therapeutics	26.35%

Insider Ownership

Company	Insider Ownership
PRG PROG	3.72%
RSI Rush Street Interactive	52.89%
UPST Upstart	17.29%
VVOS Vivos Therapeutics	2.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
PRG PROG	1,151	39.83 million	38.35 million	Not Optionable
RSI Rush Street Interactive	912	231.77 million	109.19 million	Not Optionable
UPST Upstart	1,405	97.31 million	80.49 million	Optionable
VVOS Vivos Therapeutics	268	13.90 million	13.60 million	Optionable

UPST, PRG, RSI, and VVOS Headlines

Recent News About These Companies

Vivos Therapeutics targets $3.6 million in annual cost reductions as revenue growth initiatives accelerate

September 29, 2026 | msn.com

Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives

September 29, 2026 | globenewswire.com

Vivos Therapeutics Announces Material Debt Reduction

September 8, 2026 | globenewswire.com

Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference

September 1, 2026 | newsfilecorp.comN

Vivos Therapeutics Advances South Florida Sleep Center With South Palm Cardiovascular Partnership

August 28, 2026 | rttnews.com

Vivos Therapeutics Announces Definitive Agreements With South Palm Cardiovascular Associates to Launch South Florida Sleep & Airway Medicine Center

August 28, 2026 | quiverquant.comQ

Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center

August 28, 2026 | globenewswire.com

Vivos Therapeutics Reports 212% Increase in Nevada Sleep & Airway Medicine Center Referrals Ahead of Henderson Facility Opening

August 25, 2026 | quiverquant.comQ

Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers

August 25, 2026 | globenewswire.com

Vivos Therapeutics Opens New Henderson Sleep Center, Expects Capacity to More Than Double to Over $10 Million Annually

August 20, 2026 | quiverquant.comQ

Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment

August 20, 2026 | globenewswire.com

Vivos Therapeutics shares slide after Q2 revenue falls short of forecasts

August 17, 2026 | msn.com

Vivos Therapeutics, Inc: Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update

August 15, 2026 | finanznachrichten.de

Vivos Therapeutics, Inc. (VVOS) Q2 2026 Earnings Call Transcript

August 14, 2026 | seekingalpha.com

Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates

August 14, 2026 | zacks.com

Vivos Therapeutics Reports 35% Quarterly Revenue Growth, Rising Patient Demand and Second Quarter 2026 Results

August 14, 2026 | quiverquant.comQ

Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update

August 14, 2026 | globenewswire.com

Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call

August 14, 2026 | globenewswire.com

Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations

August 11, 2026 | markets.businessinsider.com

Vivos Therapeutics Expands AI Workflow Partnership with Greenway Health, Citing Up to $9.1 Million in Annual Value at Sleep Centers of Nevada

August 11, 2026 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

UPST, PRG, RSI, and VVOS Company Descriptions

PROG NYSE:PRG

$30.42 -0.48 (-1.57%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$30.48 +0.07 (+0.23%)

As of 10/9/2026 07:30 PM Eastern

PROG Holdings, Inc. (NYSE:PRG) is a financial technology holding company based in Salt Lake City, Utah with three business segments: Progressive Leasing, which offers lease-to-own transactions primarily to credit-challenged consumers through e-commerce and point-of-sale retail partners, via online, mobile, and in-store solutions; Vive Financial, which provides consumers who may not qualify for traditional prime lending with a variety of second-look, revolving credit products through private label and branded credit cards; and Four Technologies, which provides consumers of all credit backgrounds Buy Now, Pay Later (BNPL) options through four interest-free installments via its platform, Four.

Rush Street Interactive NYSE:RSI

$18.90 -1.42 (-6.99%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$18.96 +0.06 (+0.33%)

As of 10/9/2026 07:59 PM Eastern

Rush Street Interactive, Inc. operates as an online casino and sports betting company in the United States, Canada, Mexico, and rest of Latin America. It provides real-money online casino, online and retail sports betting, and social gaming services. In addition, the company offers full suite of games comprising of bricks-and-mortar casinos, table games, and slot machines. The company markets its online casino and sports betting under BetRivers, PlaySugarHouse, and RushBet brands. Rush Street Interactive, Inc. was founded in 2012 and is headquartered in Chicago, Illinois.

Upstart NASDAQ:UPST

$24.10 -0.09 (-0.37%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$24.10 -0.01 (-0.02%)

As of 10/9/2026 07:59 PM Eastern

Upstart Holdings, Inc., together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States. Its platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small dollar loans that connects consumer demand for loans to its to bank and credit unions. Upstart Holdings, Inc. was founded in 2012 and is headquartered in San Mateo, California.

Vivos Therapeutics NASDAQ:VVOS

$0.15 0.00 (-0.40%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$0.15 0.00 (-0.60%)

As of 10/9/2026 07:35 PM Eastern

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest UPST, PRG, RSI, and VVOS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest UPST, PRG, RSI, and VVOS Earnings

Compare Dividends

Latest UPST, PRG, RSI, and VVOS Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

UPST, PRG, RSI, and VVOS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

UPST, PRG, RSI, and VVOS Company Descriptions

PROG NYSE:PRG

Rush Street Interactive NYSE:RSI

Upstart NASDAQ:UPST

Vivos Therapeutics NASDAQ:VVOS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools